Latest News, Grants & Research Reports
Read our latest news, blog posts and research updates right here
Join us at the Good Food Show Summer
Join us at the Good Food Show Summer from 18-21 June at the NEC Birmingham! With live cooking demos, celebrity chefs including James Martin, seasonal flavours, fantastic foodie shopping and more, it’s a great day out for friends and family.
Why the Rare Cancer Bill Matters: From a Neuroblastoma Parent
The House of Lords has given its final approval to the Rare Cancers Bill, meaning it can now become law. Jonathan Anderson, Tilly’s Dad, shares why this Bill is so important to him and the Neuroblastoma Community.
We are looking for new Trustees to join our Board!
Neuroblastoma UK 2025 Innovation Grants
Neuroblastoma UK has awarded three Innovation Grants, formally known as Small Grants, in 2025 and late 2024 to support fresh, early-stage research that could pave the way for better treatments for children with neuroblastoma.
Understanding OMS: Insights from Twelve Years of Collaborative Research
In 2013, Neuroblastoma UK joined forces with several other charities to fund the UK component of a unique international study into Opsoclonus Myoclonus Syndrome (OMS). This study was called the UK Multicentre Study of Children with Opsoclonus Myoclonus Syndrome (UMSCOM).
Alan Carr Stays Faithful to Neuroblastoma UK as he wins The Celebrity Traitors
Neuroblastoma UK Patron Alan Carr has won the hit BBC One show The Celebrity Traitors, produced by Studio Lambert. While bluffing, scheming, and deception may be the name of the game, one thing is certain: Alan remains truly faithful to Neuroblastoma UK.
Hall Grove School Turns Comedy into Hope
On Friday 3rd October 2025, the Hall Grove School community came together for an evening of laughter and generosity - all in support of Neuroblastoma UK.
Researchers investigating mRNA Vaccine to treat Childhood Cancer
As part of Neuroblastoma UK’s 2024 Grant Round, Dr. Olga Piskareva, alongside an international team of researchers received £208,887 to conduct research into the mRNA vaccine.
New Project to Improve Availability of Scanning Drugs, Reduce Hospital Time and Improve Radiation Dosage for Children with Cancer
As part of Neuroblastoma UK’s 2024 Grant Round, Professor Steve Archibald and his team at King’s College London received £268,301 to conduct research into improving the availability of scanning drugs to optimise radiation dose administered in children with neuroblastoma.
Blood-tests for neuroblastoma clinical trials to guide next-generation cancer treatments.
In 2021, Neuroblastoma UK awarded £469,093 in research funding to an international team of leading clinician-scientists to explore how blood tests (biomarker testing) could be used in clinical trials to improve outcomes for children with neuroblastoma.